Hôpital Beaujon

Paris 92118

0 studies enrolling now · 5 studies all time

What they study most

IgG4 Related Disease, Metastatic Pancreatic Cancer, Non-Alcoholic Steatohepatitis (NASH), Patients With Compensated Liver Cirrhosis, Short Bowel Syndrome

Studies at this site

• A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease — Running, not enrolling
• Phase 2b Study in NASH to Assess IVA337 — Completed
• Assessing Portal Hypertension With Methacetin Breath Test — Completed
• Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome — Completed
• Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas — Completed